‘Above all, do no harm’: safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis

Safeguarding patients against stem cell tourism.

Diabetes drug therapy--first do no harm.

In the November/December 2006 issue of JMCP, Watkins et al. reported the estimated value of exenatide in treating obese patients with type 2 diabetes over a 30-year time horizon, as calculated using the Center for Outcomes Research Diabetic Model, a validated Markov model that predicts clinical and economic end points over time horizons up to 100 years in duration.1 Adopting the premise that “s...

First, do no harm

Conservation agencies charged with care of threatened plant species should be governed by the concepts that conservation actions should do no harm. Adaptive management research progresses in imperfect situations due to incomplete knowledge. Interpreting new experimental or observational evidence for inclusion in conservation plans should first consider the big picture by identifying collateral ...

First, do no harm.

Accessible online at: www.karger.com/onk Fax +49 761 4 52 07 14 [email protected] www.karger.com vational study, Pinder et al. report a 26% increased risk of CHF in older women treated with adjuvant anthracyclines for breast cancer, compared with non-anthracycline regimens [8]. Cardiac troponins are regulatory proteins that control the calcium-mediated interaction of actin and myosin. The t...

First, do no harm.

Early this summer a healthy 62-year-old man with a history of colorectal cancer came to see me for his periodic health examination. In an effort to embrace patient-centred, evidence-informed decision making, much of these visits with healthy men 50 and older in my practice seems to be taken up with discussing the risks and benefits of screening for prostate cancer with a prostate-specific antig...